K2 Principal Fund’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Hold
0
314
2017
Q3
Hold
0
326
2017
Q2
Sell
-49,350
Closed -$530K 336
2017
Q1
$530K Sell
49,350
-220,186
-82% -$2.36M 0.04% 145
2016
Q4
$2.27M Buy
+269,536
New +$2.27M 0.21% 59